MedTrace Logo

Hidradenitis Suppurativa Written Action Plan

NCT04230291 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-10-01

No results posted yet for this study

Summary

This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.

Conditions

Interventions

BEHAVIORAL

Verbal consultation

Verbal consultation only without written information before receiving written action plan

BEHAVIORAL

Written Action Plan

Written handout of treatment plan and disease management strategies

Sponsors & Collaborators

  • University of Arkansas

    collaborator OTHER

  • University of Arizona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-03-17
Completion
2020-03-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04230291 on ClinicalTrials.gov